A Study of IMM0306 in IgG4-Related Disease
Clinical trial NCT07621939 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07621939
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2030-05-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.